Skip to main content

Ami Peltier

Interview
06/02/2022
IO Learning spoke with Dr Pierleone Lucatelli, an interventional radiologist at the Policlinico Umberto I in Rome, Italy, regarding his recent study examining the combination of balloon-occluded MWA followed by balloon-occluded TACE in...
IO Learning spoke with Dr Pierleone Lucatelli, an interventional radiologist at the Policlinico Umberto I in Rome, Italy, regarding his recent study examining the combination of balloon-occluded MWA followed by balloon-occluded TACE in...
IO Learning spoke with Dr...
06/02/2022
IO Learning
Interview
06/14/2022
IO Learning spoke with Gerard S. Goh, MBBS, co-investigator of a recent pilot study on the Embrace Hydrogel Embolic System for the treatment of benign and malignant hypervascular tumors.
IO Learning spoke with Gerard S. Goh, MBBS, co-investigator of a recent pilot study on the Embrace Hydrogel Embolic System for the treatment of benign and malignant hypervascular tumors.
IO Learning spoke with Gerard S....
06/14/2022
IO Learning
News
09/29/2020
CIOctober is on the horizon, with the first Tuesday evening session on October 6th focused on liver-directed therapy. The virtual meeting runs from 6-9:45 pm, EST, and all sessions will be available to registered attendees for 3 months...
CIOctober is on the horizon, with the first Tuesday evening session on October 6th focused on liver-directed therapy. The virtual meeting runs from 6-9:45 pm, EST, and all sessions will be available to registered attendees for 3 months...
CIOctober is on the horizon,...
09/29/2020
IO Learning
Dr Lucatelli
Podcast
05/31/2022
Podcast with Dr Pierleone Lucatelli, an interventional radiologist at the Policlinico Umberto I in Rome, Italy, regarding his recently published multicenter, retrospective, proof-of-concept study that examined the combination of...
Podcast with Dr Pierleone Lucatelli, an interventional radiologist at the Policlinico Umberto I in Rome, Italy, regarding his recently published multicenter, retrospective, proof-of-concept study that examined the combination of...
Podcast with Dr Pierleone...
05/31/2022
IO Learning
CIO 2020 Best Posters: Radiation Segmentectomy as Primary Therapy for HCC
Interview
11/05/2020
There is increasing evidence to support the concept of ablative-intent radioembolization, but the literature remains sparse for solitary hepatocellular carcinoma. IO Learning spoke with S. Ali Montazeri, MD, MPH, who presented his...
There is increasing evidence to support the concept of ablative-intent radioembolization, but the literature remains sparse for solitary hepatocellular carcinoma. IO Learning spoke with S. Ali Montazeri, MD, MPH, who presented his...
There is increasing evidence to...
11/05/2020
IO Learning
Interview
05/02/2022
IO Learning spoke with Isabel G. Newton, MD, PhD, Co-founder of the Interventional Initiative, a nonprofit foundation dedicated to engaging the public with credible and comprehensible information about minimally invasive, image-guided...
IO Learning spoke with Isabel G. Newton, MD, PhD, Co-founder of the Interventional Initiative, a nonprofit foundation dedicated to engaging the public with credible and comprehensible information about minimally invasive, image-guided...
IO Learning spoke with Isabel G....
05/02/2022
IO Learning
A Cost-Effectiveness Analysis of cTACE vs DEB-TACE
Interview
09/24/2020
IO Learning invited Nishita Kothary, MD, to discuss her 2020 Society of Interventional Radiology (SIR) abstract, “Comparison of Drug-Eluting Beads versus Conventional Transarterial Chemoembolization: A Cost-Effectiveness...
IO Learning invited Nishita Kothary, MD, to discuss her 2020 Society of Interventional Radiology (SIR) abstract, “Comparison of Drug-Eluting Beads versus Conventional Transarterial Chemoembolization: A Cost-Effectiveness...
IO Learning invited Nishita...
09/24/2020
IO Learning
CIO 2020 Best Posters: The EMERALD-1 Study
Interview
11/06/2020
IO Learning spoke with Riccardo Lencioni, MD, FSIR, EBIR, regarding the trial design for the EMERALD-1 study, which was recently presented at the Symposium for Clinical Interventional Oncology (CIO) and was designated as a “CIO Best...
IO Learning spoke with Riccardo Lencioni, MD, FSIR, EBIR, regarding the trial design for the EMERALD-1 study, which was recently presented at the Symposium for Clinical Interventional Oncology (CIO) and was designated as a “CIO Best...
IO Learning spoke with Riccardo...
11/06/2020
IO Learning
The Tanzania Interventional Radiology Initiative: An Update From the Road2IR Global Outreach Program
Interview
09/18/2020
Road2IR began in 2018 as a collaboration between the Yale Department of Radiology and Biomedical Imaging and Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania. It soon grew to include the Emory Department of...
Road2IR began in 2018 as a collaboration between the Yale Department of Radiology and Biomedical Imaging and Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania. It soon grew to include the Emory Department of...
Road2IR began in 2018 as a...
09/18/2020
IO Learning
Transurethral Ultrasound Ablation (TULSA) for Prostate Cancer Treatment: An Interview With  Joseph J. Busch, Jr., MD
Interview
04/18/2020
Dr Busch is the owner of the Busch Center, an imaging center in Alpharetta, Georgia that is dedicated to the diagnosis and treatment of prostate cancer. He spoke with IO Learning about integrating the recently FDA-approved TULSA...
Dr Busch is the owner of the Busch Center, an imaging center in Alpharetta, Georgia that is dedicated to the diagnosis and treatment of prostate cancer. He spoke with IO Learning about integrating the recently FDA-approved TULSA...
Dr Busch is the owner of the...
04/18/2020
IO Learning